Investing.com - Taysha Gene (NASDAQ: TSHA) reported first quarter EPS of $-0.100, better than the analyst estimate of $-0.110. Revenue for the quarter came in at $3.41M versus the consensus estimate of $2.76M.
Taysha Gene's stock price closed at $2.57. It is up 34.550% in the last 3 months and up 270.800% in the last 12 months.
Taysha Gene saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Taysha Gene's stock price’s past reactions to earnings here.
According to InvestingPro, Taysha Gene's Financial Health score is "fair performance".
Check out Taysha Gene's recent earnings performance, and Taysha Gene's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar